Background High-quality anticoagulation management is required to keep these narrow
therapeutic index medications as effective and safe as possible. This article focuses on the …

Background: Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT)
and pulmonary embolism (PE), occurs in ∼1 to 2 individuals per 1000 each year, …

In July 2022, these guidelines were reviewed by an expert work group convened by ASH.
Review included limited searches for new evidence and discussion of the search results. …

This text introduces the physical effects underlying heat and mass transfer phenomena and
develops methodologies for solving a variety of real-world problems. It emphasizes the …

We describe the development and clinical translation of a targeted polymeric nanoparticle (TNP)
containing the chemotherapeutic docetaxel (DTXL) for the treatment of patients with …

All three-manifolds are known to occur as Cauchy surfaces of asymptotically flat vacuum
spacetimes and of spacetimes with positive-energy sources. We prove here the conjecture that …

Efforts to apply nanotechnology in cancer have focused almost exclusively on the delivery
of cytotoxic drugs to improve therapeutic index. There has been little consideration of …

In April 2001, the American College of Medical Genetics (ACMG) Cystic Fibrosis (CF) Carrier
Screening Working Group recommended a panel of mutations and variants that should be …

The purpose of this article is to respond to the lack of consistency in the academic and
practitioner literature regarding the construct of employee engagement and to offer a platform for …

Cystic fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator
(CFTR) gene but the association between mutation (genotype) and disease presentation (…